Remote effects on the striatal dopamine system after fluid percussion injury

Behavioural Brain Research

Volumn 267, Issue , 2014, Pages 156-172

  Huang, Eagle Yi Kung ^a   Tsai, Tung Han ^c   Kuo, Tung Tai ^b   Tsai, Jing Jr ^c   Tsui, Pi Fen ^a   Chou, Yu Ching ^a   Ma, Hsin I ^c   Chiang, Yung Hsiao ^d   Chen, Yuan Hao ^c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Dopamine releasing and reuptake; Fast Scan Cyclic Voltammetry (FSCV); Fluid percussion injury; High pressure liquid chromatography (HPLC); Neuroinflammation

Indexed keywords

DOPAMINE;

ACUTE DISEASE; ANIMAL; BRAIN INJURY; CELL COUNT; CHRONIC DISEASE; CONVALESCENCE; CORPUS STRIATUM; ELECTROSTIMULATION; HEMISPHERIC DOMINANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MICROELECTRODE; MICROGLIA; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SPRAGUE DAWLEY RAT; TIME; TISSUE CULTURE TECHNIQUE;

ACUTE DISEASE; ANIMALS; BRAIN INJURIES; CELL COUNT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; CORPUS STRIATUM; DOPAMINE; ELECTRIC STIMULATION; FUNCTIONAL LATERALITY; IMMUNOHISTOCHEMISTRY; MALE; MICROELECTRODES; MICROGLIA; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TISSUE CULTURE TECHNIQUES;

EID: 84898630310     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.03.033     Document Type: Article

References (68)

1. Riggio S., Jagoda A. Traumatic brain injury: from bench to bedside to home. Mt Sinai J Med 2009, 76(2):95-96.
2. Riggio S., Wong M. Neurobehavioral sequelae of traumatic brain injury. Mt Sinai J Med 2009, 76(2):163-172.
3. Levin H., Kraus M.F. The frontal lobes and traumatic brain injury. J Neuropsychiatry Clin Neurosci 1994, 6(4):443-454.
4. Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth 2007;99(1):4-9.
5. Piras F., Ciullo V., Danese E., Caltagirone C., Spalletta G. Time dysperception perspective for acquired brain injury. Front Neurol 2014, 4:217.
6. Williamson J.B., Heilman K.M., Porges E.C., Lamb D.G., Porges S.W. A possible mechanism for PTSD symptoms in patients with traumatic brain injury: central autonomic network disruption. Front Neuroeng 2013, 6:13.
7. Walker KR, Tesco G. Molecular mechanisms of cognitive dysfunction following traumatic brain injury. Front Aging Neurosci 2013;5:29.
8. Bales J.W., Wagner A.K., Kline A.E., Dixon C.E. Persistent cognitive dysfunction after traumatic brain injury: a dopamine hypothesis. Neurosci Biobehav Rev 2009, 33(7):981-1003.
9. Bales J.W., Kline A.E., Wagner A.K., Dixon C.E. Targeting dopamine in acute traumatic brain injury. Open Drug Discov J 2010, 2:119-128.
10. Wagner A.K., Ren D., Conley Y.P., Ma X., Kerr M.E., Zafonte R.D., et al. Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury. J Neurosurg 2007, 106(4):538-547.
11. Kraus M.F., Maki P.M. Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review. J Neuropsychiatry Clin Neurosci 1997, 9(2):222-230.
12. McDowell S, Whyte J, D'Esposito M. Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 1998;121(Pt 6):1155-64.
13. McIntosh T.K., Yu T., Gennarelli T.A. Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J Neurochem 1994, 63(4):1426-1433.
14. Yan H.Q., Kline A.E., Ma X., Hooghe-Peters E.L., Marion D.W., Dixon C.E. Tyrosine hydroxylase: but not dopamine beta-hydroxylase, is increased in rat frontal cortex after traumatic brain injury. Neuroreport 2001, 12(11):2323-2327.
15. Huang E.Y., Tsui P.F., Kuo T.T., Tsai J.J., Chou Y.C., Ma H.I., et al. Amantadine ameliorates dopamine-releasing deficits and behavioral deficits in rats after fluid percussion injury. PLoS One 2014, 9(1):e86354.
16. Massucci J.L., Kline A.E., Ma X., Zafonte R.D., Dixon C.E. Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats. Neurosci Lett 2004, 372(1-2):127-131.
17. Plenger P.M., Dixon C.E., Castillo R.M., Frankowski R.F., Yablon S.A., Levin H.S. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil 1996, 77(6):536-540.
18. Meythaler J.M., Brunner R.C., Johnson A., Novack T.A. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil 2002, 17(4):300-313.
19. Kline A.E., Massucci J.L., Marion D.W., Dixon C.E. Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J Neurotrauma 2002, 19(4):415-425.
20. Yan H.Q., Kline A.E., Ma X., Li Y., Dixon C.E. Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex. Neuroreport 2002, 13(15):1899-1901.
21. Wang T. Amantadine improves cognitive outcome and increases neuronal survival after fluid percussion traumatic brain injury in rats. J Neurotrauma 2013.
22. Gualtieri C.T., Evans R.W. Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Inj 1988, 2(4):273-290.
23. Kraus M.F., Smith G.S., Butters M., Donnell A.J., Dixon E., Yilong C., et al. Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET). Brain Inj 2005, 19(7):471-479.
24. Sawyer E., Mauro L.S., Ohlinger M.J. Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother 2008, 42(2):247-252.
25. Frenette A.J., Kanji S., Rees L., Williamson D.R., Perreault M.M., Turgeon A.F., et al. Efficacy and safety of dopamine agonists in traumatic brain injury: a systematic review of randomized controlled trials. J Neurotrauma 2012, 29(1):1-18.
26. Matsushita Y., Shima K., Nawashiro H., Wada K. Real-time monitoring of glutamate following fluid percussion brain injury with hypoxia in the rat. J Neurotrauma 2000, 17(2):143-153.
27. McIntosh T.K., Vink R., Noble L., Yamakami I., Fernyak S., Soares H. Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 1989, 28(1):233-244.
28. Chen Y.H., Harvey B.K., Hoffman A.F., Wang Y., Chiang Y.H., Lupica C.R. MPTP-induced deficits in striatal synaptic plasticity are prevented by glial cell line-derived neurotrophic factor expressed via an adeno-associated viral vector. FASEB J 2008, 22(1):261-275.
29. Good C.H., Wang H., Chen Y.H., Mejias-Aponte C.A., Hoffman A.F., Lupica C.R. Dopamine D4 receptor excitation of lateral habenula neurons via multiple cellular mechanisms. J Neurosci 2013, 33(43):16853-16864.
30. Karperien A, Ahammer H, Jelinek HF. Quantitating the subtleties of microglial morphology with fractal analysis. Front Cell Neurosci 2013;7:3.
31. Good C.H., Hoffman A.F., Hoffer B.J., Chefer V.I., Shippenberg T.S., Backman C.M., et al. Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease. FASEB J 2011, 25(4):1333-1344.
32. Hutson C.B., Lazo C.R., Mortazavi F., Giza C.C., Hovda D., Chesselet M.F. Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat. J Neurotrauma 2011, 28(9):1783-1801.
33. Schultz W. Multiple dopamine functions at different time courses. Annu Rev Neurosci 2007, 30:259-288.
34. Thompson H.J., Lifshitz J., Marklund N., Grady M.S., Graham D.I., Hovda D.A., et al. Lateral fluid percussion brain injury: a 15-year review and evaluation. J Neurotrauma 2005, 22(1):42-75.
35. Wagner A.K., Sokoloski J.E., Ren D., Chen X., Khan A.S., Zafonte R.D., et al. Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. J Neurochem 2005, 95(2):457-465.
36. Felger J.C., Miller A.H. Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol 2012, 33(3):315-327.
37. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 2006;147(Suppl 1):S232-40.
38. Loane D.J., Byrnes K.R. Role of microglia in neurotrauma. Neurotherapeutics 2010, 7(4):366-377.
39. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009, 29(43):13435-13444.
40. Colton C.A. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009, 4(4):399-418.
41. Lawson L.J., Perry V.H., Dri P., Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990, 39(1):151-170.
42. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005;76(2):77-98.
43. Gao H.M., Hong J.S. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 2008, 29(8):357-365.
44. Baskaran H., Yarmush M.L., Berthiaume F. Dynamics of tissue neutrophil sequestration after cutaneous burns in rats. J Surg Res 2000, 93(1):88-96.
45. Bhatia R.K., Pallister I., Dent C., Jones S.A., Topley N. Enhanced neutrophil migratory activity following major blunt trauma. Injury 2005, 36(8):956-962.
46. Utagawa A., Truettner J.S., Dietrich W.D., Bramlett H.M. Systemic inflammation exacerbates behavioral and histopathological consequences of isolated traumatic brain injury in rats. Exp Neurol 2008, 211(1):283-291.
47. Felger J.C., Alagbe O., Hu F., Mook D., Freeman A.A., Sanchez M.M., et al. Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry 2007, 62(11):1324-1333.
48. Kamata M., Higuchi H., Yoshimoto M., Yoshida K., Shimizu T. Effect of single intracerebroventricular injection of alpha-interferon on monoamine concentrations in the rat brain. Eur Neuropsychopharmacol 2000, 10(2):129-132.
49. Sato T., Suzuki E., Yokoyama M., Semba J., Watanabe S., Miyaoka H. Chronic intraperitoneal injection of interferon-alpha reduces serotonin levels in various regions of rat brain: but does not change levels of serotonin transporter mRNA, nitrite or nitrate. Psychiatry Clin Neurosci 2006, 60(4):499-506.
50. Capuron L., Pagnoni G., Drake D.F., Woolwine B.J., Spivey J.R., Crowe R.J., et al. Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry 2012, 69(10):1044-1053.
51. Cunnington C., Van Assche T., Shirodaria C., Kylintireas I., Lindsay A.C., Lee J.M., et al. Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Circulation 2012, 125(11):1356-1366.
52. Haroon E., Raison C.L., Miller A.H. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012, 37(1):137-162.
53. Zhu J., Apparsundaram S., Bardo M.T., Dwoskin L.P. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex. J Neurochem 2005, 93(6):1434-1443.
54. Moron J.A., Zakharova I., Ferrer J.V., Merrill G.A., Hope B., Lafer E.M., et al. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci 2003, 23(24):8480-8488.
55. Connor T.J., Starr N., O'Sullivan J.B., Harkin A. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?. Neurosci Lett 2008, 441(1):29-34.
56. Guillemin G.J., Smith D.G., Smythe G.A., Armati P.J., Brew B.J. Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol 2003, 527:105-112.
57. Wu Y., Pearl S.M., Zigmond M.J., Michael A.C. Inhibitory glutamatergic regulation of evoked dopamine release in striatum. Neuroscience 2000, 96(1):65-72.
58. Kulagina N.V., Zigmond M.J., Michael A.C. Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience 2001, 102(1):121-128.
59. Schultz W. Behavioral dopamine signals. Trends Neurosci 2007, 30(5):203-210.
60. Floresco S.B., West A.R., Ash B., Moore H., Grace A.A. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 2003, 6(9):968-973.
61. Robinson S., Smith D.M., Mizumori S.J., Palmiter R.D. Firing properties of dopamine neurons in freely moving dopamine-deficient mice: effects of dopamine receptor activation and anesthesia. Proc Natl Acad Sci U S A 2004, 101(36):13329-13334.
62. Gariano R.F., Tepper J.M., Sawyer S.F., Young S.J., Groves P.M. Mesocortical dopaminergic neurons, 1. Electrophysiological properties and evidence for soma-dendritic autoreceptors. Brain Res Bull 1989, 22(3):511-516.
63. Janhunen S., Ahtee L. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development. Neurosci Biobehav Rev 2007, 31(3):287-314.
64. Shi W.X., Pun C.L., Smith P.L., Bunney B.S. Endogenous DA-mediated feedback inhibition of DA neurons: involvement of both D(1)- and D(2)-like receptors. Synapse 2000, 35(2):111-119.
65. Nisell M., Marcus M., Nomikos G.G., Svensson T.H. Differential effects of acute and chronic nicotine on dopamine output in the core and shell of the rat nucleus accumbens. J Neural Transm 1997, 104(1):1-10.
66. Zhang L., Doyon W.M., Clark J.J., Phillips P.E., Dani J.A. Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum. Mol Pharmacol 2009, 76(2):396-404.
67. Stock G., Magnusson T., Anden N.E. Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow. Naunyn Schmiedebergs Arch Pharmacol 1973, 278(4):347-361.
68. Wagner A.K., Drewencki L.L., Chen X., Santos F.R., Khan A.S., Harun R., et al. Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury. J Neurochem 2009, 108(4):986-997.